Head-to-Head

Dyadic International, Inc. vs. Moderna, Inc. Common Stock

DYAI

Dyadic International, Inc.

$0.42 -4.41%

VS MRNA

Moderna, Inc. Common Stock

$198.88 +2.08%

Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

DYAIMRNA
Market Cap $16.67 million $79.40 billion
Revenue (TTM) — $2.23 billion
Net Income (TTM) — $-3,151,000,000

MRNA leads on 1 of 1 size & scale factors.

Valuation

DYAIMRNA
Price / Book — 11.74
Price / Sales — 35.64

DYAI and MRNA split the valuation factors evenly.

Profitability

DYAIMRNA
Net Margin — -141.43%
Return on Equity — -46.61%

DYAI and MRNA split the profitability factors evenly.

Risk & Sentiment

DYAIMRNA
Short Interest 0.01% 0.01%

MRNA leads on 1 of 1 risk & sentiment factors.

Dig deeper: DYAI overview, DYAI financials, MRNA overview, MRNA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.